After US health secretary and hardline anti-vaccine activist Robert F. Kennedy Jr. fired all 17 highly respected vaccine experts from the federal Advisory Committee on Immunization Practices (ACIP) last month, he vetted their replacements not by medical and scientific expertise, but by their political leanings, according to a lawsuit filed by medical organizations Monday.
Under Kennedy, to qualify to be on the Centers for Disease Control and Prevention's nationally influential and historically apolitical ACIP, candidates had to be registered as a Republican or independent and could not have any history of publicly criticizing President Trump or Kennedy, the lawsuit claims.
Just two days after dismissing all 17 ACIP members—who had all gone through an extensive vetting process that lasted up to two years—Kennedy announced eight new members. One later dropped out during last-minute financial vetting the day before an ACIP meeting. Of the remaining seven, only one has the scientific and medical qualifications described under ACIP's charter.
© Getty | Win McNamee
According to a preliminary report issued by IDC today, Apple saw the strongest year-over-year growth during Q2 compared to its closest competitors in the PC market, except in the U.S., where sales basically flatlined. Here are the details
more…Apple today announced that COO Jeff Williams will retire later this year, with Sabih Khan set to assume the COO role later this month.
In addition to his role as COO, however, Williams is also responsible for overseeing Apple’s design team. Once Williams officially retires later this year, Apple says that the design team will begin reporting directly to Apple CEO Tim Cook.
more…iPadOS 26 is a major upgrade for iPad productivity, but one of the new features that makes it the most Mac-like is buried inside Settings for the dock. Here are the details.
more…
Centivax is betting big on ending the flu as we know it. The biotech startup just closed a $45 million Series A round to bring what it says could be the first universal flu vaccine into human trials. The raise […]
The post Centivax raises $45M in funding to launch first-ever universal flu vaccine to human trials first appeared on Tech Startups.
